These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 21118496
1. Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer. Langer W, Sohler F, Leder G, Beckmann G, Seidel H, Gröne J, Hummel M, Sommer A. BMC Genomics; 2010 Nov 30; 11():676. PubMed ID: 21118496 [Abstract] [Full Text] [Related]
2. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. de Miguel FJ, Sharma RD, Pajares MJ, Montuenga LM, Rubio A, Pio R. Cancer Res; 2014 Feb 15; 74(4):1105-15. PubMed ID: 24371231 [Abstract] [Full Text] [Related]
3. A statistical method for predicting splice variants between two groups of samples using GeneChip expression array data. Fan W, Khalid N, Hallahan AR, Olson JM, Zhao LP. Theor Biol Med Model; 2006 Apr 07; 3():19. PubMed ID: 16603076 [Abstract] [Full Text] [Related]
4. Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation. Ha KCh, Coulombe-Huntington J, Majewski J. BMC Genomics; 2009 Nov 12; 10():519. PubMed ID: 19909511 [Abstract] [Full Text] [Related]
5. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Xi L, Feber A, Gupta V, Wu M, Bergemann AD, Landreneau RJ, Litle VR, Pennathur A, Luketich JD, Godfrey TE. Nucleic Acids Res; 2008 Nov 12; 36(20):6535-47. PubMed ID: 18927117 [Abstract] [Full Text] [Related]
6. Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer. Misquitta-Ali CM, Cheng E, O'Hanlon D, Liu N, McGlade CJ, Tsao MS, Blencowe BJ. Mol Cell Biol; 2011 Jan 12; 31(1):138-50. PubMed ID: 21041478 [Abstract] [Full Text] [Related]
7. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma. Lee LN, Kuo SH, Lee YC, Chang YL, Chang HC, Jan IS, Yang PC. J Formos Med Assoc; 2005 Aug 12; 104(8):541-8. PubMed ID: 16193174 [Abstract] [Full Text] [Related]
8. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, Davies C, Williams A, Turpaz Y. BMC Genomics; 2006 Dec 27; 7():325. PubMed ID: 17192196 [Abstract] [Full Text] [Related]
9. Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer. Pio R, Blanco D, Pajares MJ, Aibar E, Durany O, Ezponda T, Agorreta J, Gomez-Roman J, Anton MA, Rubio A, Lozano MD, López-Picazo JM, Subirada F, Maes T, Montuenga LM. BMC Genomics; 2010 Jun 03; 11():352. PubMed ID: 20525254 [Abstract] [Full Text] [Related]
10. A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays. Yoshida R, Numata K, Imoto S, Nagasaki M, Doi A, Ueno K, Miyano S. Genome Inform; 2006 Jun 03; 17(1):88-99. PubMed ID: 17503359 [Abstract] [Full Text] [Related]
11. Discovery of tissue-specific exons using comprehensive human exon microarrays. Clark TA, Schweitzer AC, Chen TX, Staples MK, Lu G, Wang H, Williams A, Blume JE. Genome Biol; 2007 Jun 03; 8(4):R64. PubMed ID: 17456239 [Abstract] [Full Text] [Related]
12. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing. Dong L, Jensen RV, De Rienzo A, Gordon GJ, Xu Y, Sugarbaker DJ, Bueno R. BMC Med Genet; 2009 Dec 31; 10():149. PubMed ID: 20043850 [Abstract] [Full Text] [Related]
13. The comparison of different pre- and post-analysis filters for determination of exon-level alternative splicing events using Affymetrix arrays. Whistler T, Chiang CF, Lin JM, Lonergan W, Reeves WC. J Biomol Tech; 2010 Apr 31; 21(1):44-53. PubMed ID: 20357982 [Abstract] [Full Text] [Related]
14. Prognostic alternative mRNA splicing signature in non-small cell lung cancer. Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J. Cancer Lett; 2017 May 01; 393():40-51. PubMed ID: 28223168 [Abstract] [Full Text] [Related]
15. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells. Chang JG, Yang DM, Chang WH, Chow LP, Chan WL, Lin HH, Huang HD, Chang YS, Hung CH, Yang WK. PLoS One; 2011 May 01; 6(6):e18643. PubMed ID: 21694768 [Abstract] [Full Text] [Related]
16. L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma. Wang T, Fan L, Watanabe Y, McNeill P, Fanger GR, Persing DH, Reed SG. Oncogene; 2001 Nov 22; 20(53):7699-709. PubMed ID: 11753648 [Abstract] [Full Text] [Related]
17. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities. Bemmo A, Dias C, Rose AA, Russo C, Siegel P, Majewski J. PLoS One; 2010 Aug 06; 5(8):e11981. PubMed ID: 20700505 [Abstract] [Full Text] [Related]
18. Comprehensive exon array data processing method for quantitative analysis of alternative spliced variants. Chen P, Lepikhova T, Hu Y, Monni O, Hautaniemi S. Nucleic Acids Res; 2011 Oct 06; 39(18):e123. PubMed ID: 21745820 [Abstract] [Full Text] [Related]
19. A robust estimation of exon expression to identify alternative spliced genes applied to human tissues and cancer samples. Risueño A, Roson-Burgo B, Dolnik A, Hernandez-Rivas JM, Bullinger L, De Las Rivas J. BMC Genomics; 2014 Oct 08; 15(1):879. PubMed ID: 25297679 [Abstract] [Full Text] [Related]
20. RNA sequencing and transcriptome arrays analyses show opposing results for alternative splicing in patient derived samples. Nazarov PV, Muller A, Kaoma T, Nicot N, Maximo C, Birembaut P, Tran NL, Dittmar G, Vallar L. BMC Genomics; 2017 Jun 06; 18(1):443. PubMed ID: 28587590 [Abstract] [Full Text] [Related] Page: [Next] [New Search]